You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leucovorin

Showing 1 - 25 of 1,834
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Nov 13, 2022

Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Language Disorders
  • Levoleucovorin Calcium
  • Placebo
  • Phoenix, Arizona
  • +1 more
Sep 26, 2022

Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Language Disorders
  • Levoleucovorin Calcium
  • Placebo
  • Phoenix, Arizona
  • +1 more
Oct 7, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Phoenix, Arizona
  • +5 more
Dec 15, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,

Recruiting
  • Colorectal Cancer
  • +4 more
  • Fosifloxuridine Nafalbenamide
  • +4 more
  • Wichita, Kansas
  • +5 more
Jan 9, 2023

Colorectal Cancer Trial in Frankfurt, Zurich (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Frankfurt, Germany
  • +1 more
Oct 3, 2022

Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • nanoliposomal irinotecan
  • spleen irradiation
  • (no location specified)
May 8, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)

Recruiting
  • Gastric Cancer
  • +3 more
  • leucovorin, oxaliplatin, docetaxel, S-1
  • Kaohsiung, Taiwan
  • +3 more
May 24, 2022

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)

Terminated
Has Results
  • Colorectal Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 10, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +5 more
  • Biospecimen Collection
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Oct 11, 2023

Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)

Withdrawn
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFIRI regimen
  • +7 more
  • Boulogne Billancourt, France
    Hopital Ambroise Pare
Aug 26, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022

Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

Active, not recruiting
  • Biliary Tract Cancer
  • Ann Arbor, Michigan
  • +4 more
Oct 6, 2022

Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Jun 17, 2022

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)

Not yet recruiting
  • Pancreatic Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023

Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)

Active, not recruiting
  • Esophageal Carcinoma
  • Rochester, New York
    University of Rochester
Aug 17, 2022

Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)

Recruiting
  • Colorectal Cancer
  • mFOLFOXIRI plus Bevacizumab
  • mFOLFOX6 Plus Bevacizumab
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022